medicate
  • About
    • About Tensive
    • Management team
    • Board of Directors
    • Scientific advisors
  • Unmet need
  • Technology
  • Pipeline
  • Investors & Media
    • Investors
    • Press Releases
    • Events
    • Publications
  • Careers
Contact us

Press releases

  1. Home
  2. Archive by category : "Press releases"
  3. (
  4. Page 2
  5. )
  • officine
  • 0 Comments
Tensive is awarded by the European Innovation Council Accelerator for its project REGENERA

Milan, Italy – December 19th, 2022 Tensive S.r.l., the medical technology company pioneering innovative solutions for reconstructive surgery, announces that […]

Read More
  • officine
  • 0 Comments
L’azienda biomedicale Tensive riceve fondi attraverso il programma Horizon 2020 SME Instrument dell’ Unione Europea (in Italian)

Milano, 31 Maggio 2018 Tensive S.r.l., azienda biomedicale pioniera nello sviluppo di protesi innovative per la ricostruzione e l’aumento del […]

Read More
  • officine
  • 0 Comments
Tensive riceve un investimento di 500 mila euro da Unicredit e Invitalia Ventures (in Italian)

Tensive, fondata a Milano come spin-off di Fondazione Filarete, sta sviluppando una protesi basata su un biomateriale sintetico e biodegradabile, […]

Read More
  • officine
  • 0 Comments
Tensive chiude un round di finanziamento da 1,4 milioni di Euro (in Italian)

(Comunicato Stampa) 2 febbraio 2016 La startup biomedicale Tensive ha ricevuto il primo finanziamento di 1,4 milioni di Euro, grazie […]

Read More
  • Previous page
  • 1
  • 2

Categories

  • Events
  • Press releases
    • Press Releases in English
    • Press Releases in Italian
medicate-footer-logo

The breast implants are under development and are not commercially available.

Quick Links

  • Unmet need
  • Pipeline
  • Our Investors
  • Publications

Contact Us

  • +39 02 5666 0265
  • [email protected]
  • [email protected]
Copyright TENSIVE s.r.l. © 2016-2025 All rights reserved
Via Timavo, 34 20124 Milan (Italy) | Reg. Imprese MI/C.F./VAT 08045870964 | Capital: 42,036.40 | Privacy | Cookies | Credits | Trasparenza